𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic studies of cimetidine in patients with liver disease

✍ Scribed by Yamasaki, Hiroko ;Arima, Terukatsu ;Nagashima, Hideo

Book ID
110679510
Publisher
Springer-Verlag
Year
1987
Tongue
English
Weight
468 KB
Volume
22
Category
Article
ISSN
0435-1339

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cimetidine Kinetics and Dynamics in Pati
Cimetidine Kinetics and Dynamics in Patients with Severe Liver Disease
✍ Jean-Pierre Villeneuve; HΓ©lΓ¨ne Fortunet-Fouin; Dominique ArsΓ¨ne πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 536 KB

Following cimetidine administration, 60% of the dose is excreted as unchanged drug in the urine, and 40% is eliminated by metabolism. We evaluated the effect of liver disease on cimetidine disposition by comparing its kinetics in 7 healthy subjects and 8 patients with alcoholic cirrhosis. Cirrhotic

Pharmacokinetics of isradipine in patien
Pharmacokinetics of isradipine in patients with chronic liver disease
✍ J. Cotting; J. Reichen; K. Kutz; R. Laplanche; E. NΓΌesch πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 523 KB

The pharmacokinetics of the dihydropyridine calcium antagonist isradipine has been examined in 8 healthy volunteers, 7 patients with non-cirrhotic chronic liver disease (CLD), and 8 patients with biopsy-proven cirrhosis (CIR). Isradipine was simultaneously given orally (12C 5 mg) and i.v. (13C 1 mg)